Galenic formulations of organic compounds

Details for Australian Patent Application No. 2009202069 (hide)

Owner Novartis AG

Inventors Rigassi-Dietrich, Petra Gisela; Schmid, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2009202069

Parent 2005224010

Filing date 26 May 2009

Wipo publication date 18 June 2009

Acceptance publication date 16 February 2012

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/00 (2006.01)

Event Publications

11 June 2009 Complete Application Filed

18 June 2009 Application Open to Public Inspection

  Published as AU-B-2009202069

16 February 2012 Application Accepted

  Published as AU-B-2009202069

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202070-Armored hull

2009202068-Method and system for transferring transmit power control information between network management entities in a wireless communication system